Dream come true': Indian-American Ananya Vinay wins US National Spelling Bee

June 2, 2017

Oxon Hill, Jun 2: Ananya Vinay never looked all that impressed by any of the words she was given in the finals of the Scripps National Spelling Bee.

spell-bee

The 12-year-old from Fresno, California, showed little emotion and didn't take much time as she plowed through word after word. Sometimes she would blurt out questions, with little intonation — “Part of speech?” ''Language of origin?” — and sometimes she didn't even bother.

Unflappable to the end, Ananya seized the opportunity when her steely opponent, Rohan Rajeev, flubbed a simple-looking but obscure Scandinavian-derived word, “marram,” which means a beach grass. She calmly nailed two words in a row, ending on “marocain,” which means a type of dress fabric of ribbed crepe, to win the 90th Scripps National Spelling Bee on Thursday.

Ananya barely cracked a smile even when her parents and younger brother stormed onto the stage to embrace her as the confetti fell. And she took time to console Rohan, who remained in his seat, wiping tears from his eyes.

“It's like a dream come true,” Ananya said as she held the trophy. “I'm so happy right now.”

She will take home more than $40,000 in cash and prizes.

It was the first time since 2013 that the bee declared a sole champion. After three straight years of ties, the bee added a tiebreaker test this year, and it looked like it might come into play as Ananya and Rohan dueled for nearly 20 rounds.

Ananya was on the radar of some veteran bee watchers but didn't come in with a high profile. She participated in last year's bee but didn't make the top 50. As a sixth-grader, she could have come back for two more years, had she fallen short. Now, she'll return only in a ceremonial role to help present the trophy to next year's winner.

For Rohan, a 14-year-old eighth-grader from Edmond, Oklahoma, it was his first and only time on the national stage, but he's competed for years in other bees and he sought tutelage from another Oklahoman, Cole Shafer-Ray, who finished third two years ago. Rohan's close call was even more heartbreaking.

Ananya is the 13th consecutive Indian-American to win the bee and the 18th of the past 22 winners with Indian heritage, a run that began in 1999 with Nupur Lala's victory, which was featured in the documentary “Spellbound.” Like most of her predecessors, she honed her craft in highly competitive national bees that are limited to Indian-Americans, the North South Foundation and the South Asian Spelling Bee, although she did not win either.

Mira Dedhia, trying to become the first offspring of a past competitor to win, finished third.

Before Ananya and Rohan began their lengthy duel, the primetime finals were marked by surprising eliminations of better-known spellers. Shourav Dasari, a past winner of both minor-league bees, was described as the consensus favorite as the ESPN broadcast began. He had the most swagger of the finalists, at one point spelling the word “Mogollon” as soon as he heard it and turning around to return to his seat.

He was felled in fourth place by a killer word, “Struldbrug,” that was coined by Jonathan Swift in his novel “Gulliver's Travels” and had no recognizable roots or language patterns to fall back on.

“I was honestly, absolutely shocked. It was stunning,” former speller Jacob Williamson said. “Shourav is one of the greatest spellers of all time and he's probably the best speller that never won.”

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
April 2,2020
Thailand's controversial king has created a category of his own with his idea of self-isolation.
 
According to reports, King Maha Vajiralongkorn, also known as Rama X, has hired out an entire luxury hotel in Germany, where he has been 'self-isolating' with 20 women.
 
The luxury hotel, the Grand Hotel Sonnenbichl, is in the Alpine resort town of Garmisch-Partenkirchen.
 
The 67-year-old king is self-isolating with his entourage that includes a 'harem' of 20 concubines and several servants, reported Bild.
 
However, it is unclear if his four wives are currently living in the same hotel.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
May 27,2020

Geneva, May 27: The number of confirmed cases of COVID-19 worldwide has increased by nearly 100,000 over the past 24 hours to surpass 5.4 million, the World Health Organisation (WHO) said.

According to the WHO, the global case tally currently stands at 5,404,512 -- a rise by 99,780 over the past day.

The death count worldwide amounts to 343,514 -- an increase by 1,486.

Most cases of infection are recorded in the Americas -- 2,454,452, with 143,739 deaths.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
March 25,2020

Beijing, Mar 25: Around 5,000 people have signed up for the phase I clinical trial of recombinant novel coronavirus vaccine in Chinese city Wuhan where the virus first emerged late last year.

The recruitment for participants ended this week with nearly 5,000 volunteers signing up for the trial, state-run Beijing News reported on Wednesday.

A single-centre, open and dose-escalation phase I clinical trial for recombinant novel coronavirus vaccine (adenoviral vector) will be tested in healthy adults aged between 18 and 60 years, according to the ChiCTR (China Clinical Trial Register).

The trial, led by experts from the Academy of Military Medical Sciences, gained its approval on March 16 and the research is expected to last half a year.

Requiring at least 108 participants, the trial will be conducted in Wuhan, capital of Hubei province, the region worst-affected by the virus in the country, state-run China Daily reported.

Participants will experience 14-day quarantine restrictions after being vaccinated and their health condition will be recorded every day.

Chinese scientists are hastening the development of COVID-19 vaccines through five approaches --- inactivated vaccines, genetic engineering subunit vaccines, adenovirus vector vaccines, nucleic acid vaccines and vaccines using attenuated influenza virus as vectors.

So far, most teams are expected to complete preclinical research in April and some are moving forward faster, Wang Junzhi, an academician with the Chinese Academy of Engineering said.

Wang noted that research and development of COVID-19 vaccines in China is not slower than foreign counterparts and has been carried out in a scientific, standardised and orderly way.

China has stepped up the process to finalise vaccines to counter COVID-19 after Kaiser Permanente research facility in Seattle and Washington stole the march and began human trials.

China lifted tough restrictions on the Hubei province on Wednesday after a months-long lockdown as the country reported no new domestic cases.

But there were another 47 imported infections from overseas, the National Health Commission said. In total, 474 imported infections have been diagnosed in China -- mostly Chinese nationals returning home.

Comments

Y UDAYA CHANDAR
 - 
Monday, 13 Apr 2020

Dear Sir,

 

I am 77 but a very healthy person with remarkable immunity. I contracted Malaria fever in 1994 because of mosquito biting and I have not been sick anytime there after, not even for ordinary fever in the last 26 years.

 

I am sure you would like to conduct the trials on persons of varying criteria. I am sure you don't want to carry out the trials on perfectly healthy young individuals only. 

 

I am certain that  you want to try the vaccine on a 'common man' from 'general public.' I am ready for the trial and you can take me. I will be delighted. 

 

If you are not handling this matter kindly forward this mail to the correct agency.

 

I look forward to hearing from you.

 

Best regards.

 

If you are not moving forward, you are really moving backward.

Y Udaya Chandar

 

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.